BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 20385637)

  • 21. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets.
    Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Mann JJ
    Am J Psychiatry; 2007 Jul; 164(7):1044-9. PubMed ID: 17606656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT reuptake inhibitors, tricyclic antidepressants and suicidal behaviour.
    Baldwin D; Bullock T; Montgomery D; Montgomery S
    Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():49-55; discussion 55-6. PubMed ID: 1839632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suicidality in pediatric patients treated with antidepressant drugs.
    Hammad TA; Laughren T; Racoosin J
    Arch Gen Psychiatry; 2006 Mar; 63(3):332-9. PubMed ID: 16520440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant use and risk of suicide and attempted suicide or self harm in people aged 20 to 64: cohort study using a primary care database.
    Coupland C; Hill T; Morriss R; Arthur A; Moore M; Hippisley-Cox J
    BMJ; 2015 Feb; 350():h517. PubMed ID: 25693810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic appraisal of citalopram in the management of single-episode depression.
    Sclar DA; Skaer TL; Robison LM; Galin RS
    J Clin Psychopharmacol; 1999 Oct; 19(5 Suppl 1):47S-54S. PubMed ID: 10507508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief report: paroxetine in younger and adult individuals at high risk for suicide.
    Bauer MS; Wisniewski SR; Kogan JN; Marangell LB; Thase ME; Sachs G
    Psychopharmacol Bull; 2006; 39(1):31-7. PubMed ID: 17065973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A black-box warning for antidepressants in children?
    Newman TB
    N Engl J Med; 2004 Oct; 351(16):1595-8. PubMed ID: 15483275
    [No Abstract]   [Full Text] [Related]  

  • 29. Suicidal risk during controlled clinical investigations of fluvoxamine.
    Letizia C; Kapik B; Flanders WD
    J Clin Psychiatry; 1996 Sep; 57(9):415-21. PubMed ID: 9746450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressants and pediatric depression--the risk of doing nothing.
    Brent DA
    N Engl J Med; 2004 Oct; 351(16):1598-601. PubMed ID: 15483276
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective serotonin reuptake inhibitors and the risk for suicidality in adolescents: an update.
    Giner L; Nichols CM; Zalsman G; Oquendo MA
    Int J Adolesc Med Health; 2005; 17(3):211-20. PubMed ID: 16231472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults.
    Katz LY; Kozyrskyj AL; Prior HJ; Enns MW; Cox BJ; Sareen J
    CMAJ; 2008 Apr; 178(8):1005-11. PubMed ID: 18390943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.
    KoKoAung E; Cavenett S; McArthur A; Aromataris E
    JBI Database System Rev Implement Rep; 2015 Apr; 13(3):174-205. PubMed ID: 26447056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suicidal risk from TADS study was higher than it first appeared.
    Högberg G; Antonuccio DO; Healy D
    Int J Risk Saf Med; 2015; 27(2):85-91. PubMed ID: 26410011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which SSRIs most effectively treat depression in adolescents?
    DeLucia V; Kelsberg G; Safranek S
    J Fam Pract; 2016 Sep; 65(9):632-4. PubMed ID: 27672691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Selective serotonin reuptake inhibitors and mammary pathologies].
    Shchepotin IB; Zotov AS; Dobzhenko MN
    Vopr Onkol; 2010; 56(4):393-7. PubMed ID: 20968014
    [No Abstract]   [Full Text] [Related]  

  • 38. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
    Morrison J; Schwartz TL
    Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy in depressed children and adolescents.
    Taurines R; Gerlach M; Warnke A; Thome J; Wewetzer C
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():11-5. PubMed ID: 21905988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports.
    Khan A; Khan S; Kolts R; Brown WA
    Am J Psychiatry; 2003 Apr; 160(4):790-2. PubMed ID: 12668373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.